BioSpace News Archive

Tarsus Pharmaceuticals, Inc., whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize treatment for patients, starting with eye care, announced financial results for the first quarter ended March 31, 2024.

Revolution Medicines, Inc., a clinical-stage oncology company developing targeted therapies for patients with RAS-addicted cancers, announced its financial results for the quarter ended March 31, 2024, and provided an update on corporate progress.

OraSure Technologies, Inc., a leader in point-of-care and home diagnostic tests and sample management solutions, announced its financial results for the three months ended March 31, 2024.

Xenon Pharmaceuticals Inc. announced that the company will present at the BofA Securities Health Care Conference 2024 taking place May 14-16, 2024 in Las Vegas, NV.

Obsidian Therapeutics, Inc. today announced the appointment of Dana Alexander as Chief Technical Officer.

Aptevo Therapeutics Inc. (NASDAQ:APVO), a clinical-stage biotechnology company focused on developing novel immune-oncology therapeutics based on its proprietary ADAPTIR™ and ADAPTIR-FLEX™ platform technologies, today reported financial results for the quarter ended March 31, 2024 and provided a business update.

Halozyme Therapeutics, Inc. today announced that Nicole LaBrosse, Chief Financial Officer, is scheduled to present and host investor meetings at the following investor conferences.

Neurocrine Biosciences, Inc. (Nasdaq: NBIX), today announced the initiation of its Phase 1 first-in-human clinical study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of investigational compound NBI-1117567 in healthy adult participants.

Moleculin Biotech, Inc. today announced that it will report its financial results for the quarter ended March 31, 2024, on Friday, May 10, 2024.

Neogen Corporation (NASDAQ: NEOG) announced today that the Company will participate in the Bank of America 2024 Health Care Conference in Las Vegas, Nevada, on Wednesday, May 15, 2024.